Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation Qayed, Muna

6 3 p. 746-749
artikel
2 ABCB6 polymorphisms are not overly represented in patients with porphyria Farrell, Colin P.

6 3 p. 760-766
artikel
3 A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia Ng, Stanley W.K.

6 3 p. 1064-1073
artikel
4 Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 Wygrecka, Malgorzata

6 3 p. 1074-1087
artikel
5 An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice Joseph, Bilgimol Chumappumkal

6 3 p. 959-969
artikel
6 Antithrombin protects against Plasmodium falciparum histidine-rich protein II-mediated inflammation and coagulation Biswas, Indranil

6 3 p. 931-945
artikel
7 Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation Lakkaraja, Madhavi

6 3 p. 1054-1063
artikel
8 ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome West, Robert R.

6 3 p. 793-807
artikel
9 Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis Locatelli, Franco

6 3 p. 1004-1014
artikel
10 Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 Piñana, José Luis

6 3 p. 848-853
artikel
11 C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 Aiello, Sistiana

6 3 p. 866-881
artikel
12 Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Jiménez, Moraima

6 3 p. 774-784
artikel
13 Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma Mohan, Meera

6 3 p. 808-817
artikel
14 Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia Kaur, Manraj N.

6 3 p. 785-792
artikel
15 Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation Nunez, Lina

6 3 p. 767-773
artikel
16 Daratumumab for immune thrombotic thrombocytopenic purpura van den Berg, Jana

6 3 p. 993-997
artikel
17 Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia Fitch, Briana A.

6 3 p. 854-865
artikel
18 Editorial Board
6 3 p. i
artikel
19 Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo Zhang, Xiaoshan

6 3 p. 891-901
artikel
20 Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study Böttcher, Sebastian

6 3 p. 976-992
artikel
21 GRNDaD: big data and sickle cell disease Lanzkron, Sophie

6 3 p. 1088
artikel
22 Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry Jones, David A.

6 3 p. 909-919
artikel
23 LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells Holdreith, Nicholas

6 3 p. 731-745
artikel
24 Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura Borogovac, Azra

6 3 p. 750-759
artikel
25 Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD Yadegari, Hamideh

6 3 p. 1038-1053
artikel
26 Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors Schweiger, Helmut

6 3 p. 946-958
artikel
27 Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics Hamadani, Mehdi

6 3 p. 920-930
artikel
28 Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma Bröske, Ann-Marie E.

6 3 p. 1025-1037
artikel
29 Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1 Oñate, Guadalupe

6 3 p. 882-890
artikel
30 Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study Van Der Valk, Paul

6 3 p. 902-908
artikel
31 Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy Castillo, Jorge J.

6 3 p. 1015-1024
artikel
32 Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML Menghrajani, Kamal

6 3 p. 828-847
artikel
33 Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma Liu, Ying

6 3 p. 717-730
artikel
34 Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience Diarra, Ava

6 3 p. 998-1003
artikel
35 t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity Mueller, Sarah B.

6 3 p. 818-827
artikel
36 Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis Eder, Sebastian K.

6 3 p. 970-975
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland